×
About 1,613 results

ALLMedicine™ Insulinoma Center

Research & Reviews  621 results

Technical aspects of pediatric robotic pancreatic enucleation based on a case of an ins...
https://doi.org/10.1002/rcs.2317
The International Journal of Medical Robotics + Computer ... Schulte Am Esch J, Krüger M et. al.

Jul 24th, 2021 - Insulinomas are rare insulin-producing pancreatic neuroendocrine tumors leading to severe episodes of hypoglycemia. Surgery is the predominant curative therapy. We report here the first pediatric case of an insulinoma of the pancreatic body resect...

Complete Resolution of Disease After Peptide Receptor Radionuclide Therapy in a Patient...
https://doi.org/10.1097/RLU.0000000000003831
Clinical Nuclear Medicine; Verma P, Malhotra G et. al.

Jul 21st, 2021 - A 48-year-old man, a case of metastatic insulinoma, who failed transarterial chemoembolization of liver metastases underwent multiple cycles of peptide receptor radionuclide therapy with 177Lu-DOTATATE, following which a complete morphologic and m...

Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in ...
https://doi.org/10.1515/jpem-2021-0289
Journal of Pediatric Endocrinology & Metabolism : JPEM; Messaaoui A, Hajselova L et. al.

Jul 20th, 2021 - Questions are emerging concerning the long-term consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, as a possible increase in type 1 diabetes. This study aims to describe the prevalence of anti-SARS-CoV-2 ant...

Values of 68Ga-DOTATOC and Carbidopa-assisted 18F-DOPA PET/CT for insulinoma localization.
https://doi.org/10.2967/jnumed.121.262401
Journal of Nuclear Medicine : Official Publication, Socie... Imperiale A, Boursier C et. al.

Jul 18th, 2021 - To assess the value of 68Ga-DOTATOC and carbidopa-assisted 18F-DOPA in 21 hypoglycaemic patients. Methods: All patients who underwent 68Ga-DOTATOC and/or carbidopa-assisted 18F-DOPA PET/CT for suspicion of insulinoma from January 2019 to January 2...

Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
https://doi.org/10.2967/jnumed.120.246009
Journal of Nuclear Medicine : Official Publication, Socie... Wild D, Antwi K et. al.

Jul 8th, 2021 - The glucagon-like peptide-1 receptor (GLP-1R) is an emerging target due to its high expression in benign insulinomas as well as in islet cell hypertrophia/hyperplasia (nesidioblastosis) and pancreatic β-cells. In 2008, occult insulinomas were loca...

see more →

Clinicaltrials.gov  4 results

Live Enterovirus Vaccine and Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02961595

Nov 11th, 2016 - Enteroviruses have been associated with type 1 diabetes in several studies. Enterovirus infections may either increase or decrease the risk of type 1 diabetes depending on the age of infection and the type of enterovirus in question. There is rema...

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
https://clinicaltrials.gov/ct2/show/NCT02560376

Sep 25th, 2015 - 68Ga-NOTA-exendin-4 is an optimal probe targeting GLP-1R. The investigators will determine the use of 68Ga-NOTA-exendin-4 PET/CT in the detection of insulinomas, and to compare its diagnostic value with conventional imaging. GLP-1R imaging, specif...

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
https://clinicaltrials.gov/ct2/show/NCT00005910

Mar 4th, 2008 - Patients with the clinical diagnosis of hypoglycemia secondary to a putative insulin secreting pancreatic neuroendocrine tumor require accurate localization of the tumor and definitive surgical resection. Non-invasive pre-operative imaging studies...

EUS-guided Ethanol Ablation of an Insulinoma
https://clinicaltrials.gov/ct2/show/NCT02121366

As the major insulinomas are functioning islet cell tumors, surgical resection is currently first-line therapy for or treatment of insulinomas. However, the surgical resection of pancreatic neoplasm is conditional for specific patients and may be ...

see more →

News  19 results

Mystery hypoglycemia case highlights troublesome diagnosis
https://www.mdedge.com/familymedicine/article/200734/diabetes/mystery-hypoglycemia-case-highlights-troublesome-diagnosis?channel=39313
MDedge Endocrinology; Randy Dotinga

May 11th, 2019 - LOS ANGELES – The 69-year-old woman with a history of type 2 diabetes had persistent hypoglycemia despite treatment with hydrocortisone, dextrose, and glucagon. Doctors in South Carolina worried about insulinoma and planned to launch an intra-arte.

Clinical Challenges - February 2018 What's your diagnosis?
https://www.mdedge.com/gihepnews/article/157654/clinical-challenges-february-2018-whats-your-diagnosis

Feb 2nd, 2018 - The diagnosis: Metastatic insulinoma surrounded by steatotic hepatocytes The loss of L-FABP expression in steatotic hepatocytes is the hallmark of HNF1alpha-inactivated liver adenoma,1 and clearly suggested this diagnosis. However, the emergence o.

Genomic Diversity Clouds Outlook for Neuroendocrine Tumors
https://www.onclive.com/publications/oncology-live/2016/vol-17-no-10/genomic-diversity-clouds-outlook-for-neuroendocrine-tumors

Sep 8th, 2016 - Despite a spate of therapeutic advances in recent years, neuroendocrine (NET) tumors remain a poorly investigated collection of cancers whose rarity has limited clinical trial enrollment. Now, genome sequencing studies are providing clues for ther...

High-dose oral insulin offers immunotherapy hope against type 1 diabetes
https://www.mdedge.com/familymedicine/article/98927/endocrinology/high-dose-oral-insulin-offers-immunotherapy-hope-against
Clinical Endocrinology News; Bianca Nogrady

Apr 21st, 2015 - High-dose oral insulin induces an immune response in children at high risk of developing type 1 diabetes but without causing hypoglycemia or triggering immune responses typical of type 1 diabetes, a pilot study showed. Children aged 2-7 with a fam.

Oral Insulin May Thwart Type 1 Diabetes in High-Risk Kids
https://www.medscape.com/viewarticle/843468

Apr 21st, 2015 - In the Pre-POINT pilot study, five of six children who were at extremely high risk of developing type 1 diabetes and who received a high dose of oral insulin had a protective immune response, and the insulin did not cause hypoglycemia. "These find...

see more →

Patient Education  1 results see all →